EUVIMEDEUVIMED entdecken
Open Access

Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex

Qiqi Shi, Bo Yu, Yingwen Zhang, Yi Yang, Chenxin Xu, Mingda Zhang, Guoyu Chen, Fei Luo, Bowen Sun, Ru Yang, Yanxin Li, Haizhong Feng

Cellular Oncology · 2023-12 · 46 (6) · 1763-1775

DOI: 10.1007/s13402-023-00843-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 19.07.2023. Verfasst von Qiqi Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine, State Key Laboratory of Systems Medic…. Hauptthemen laut MEDLINE: Neuroblastoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaMiceAnimalsHumansMice, NudeAgarCell Line, TumorMice, KnockoutCell DifferentiationTretinoinMice, TransgenicHistone DemethylasesGene Expression Regulation, NeoplasticCarrier Proteins

Stichwörter der Autor:innen

DifferentiationLSD1NeuroblastomaRetinoic acidTRIM24

Substanzen

AgarTretinoinHistone DemethylasesTRIM24 protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shang…
  • Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University, Shanghai, 200127, China…

Zitieren

APA

Shi, Q., Yu, B., Zhang, Y., Yang, Y., Xu, C., Zhang, M., Chen, G., Luo, F., Sun, B., Yang, R., Li, Y., & Feng, H. (2023). Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex. Cellular Oncology, 46(6), 1763-1775. https://doi.org/10.1007/s13402-023-00843-4

Vancouver

Shi Q, Yu B, Zhang Y, Yang Y, Xu C, Zhang M, et al. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex. Cellular Oncology. 2023;46(6):1763-1775. doi:10.1007/s13402-023-00843-4

BibTeX
@article{Shi2023,
  author = {Shi, Qiqi and Yu, Bo and Zhang, Yingwen and Yang, Yi and Xu, Chenxin and Zhang, Mingda and Chen, Guoyu and Luo, Fei and Sun, Bowen and Yang, Ru and Li, Yanxin and Feng, Haizhong},
  title = {Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex},
  journal = {Cellular Oncology},
  year = {2023},
  volume = {46},
  number = {6},
  pages = {1763--1775},
  doi = {10.1007/s13402-023-00843-4}
}
Kostenlos starten →